US Stock MarketDetailed Quotes

DARE Dare Bioscience

Watchlist
  • 3.2300
  • -0.0400-1.22%
Close Dec 30 16:00 ET
28.10MMarket Cap-5.57P/E (TTM)

Dare Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-95.83%41.69K
22.44K
9.3K
-71.92%2.81M
1.81M
1M
0
0
10M
0
Operating revenue
-95.83%41.69K
--22.44K
--9.3K
-71.92%2.81M
--1.81M
--1M
--0
--0
--10M
--0
Cost of revenue
0
0
7.67K
0
0
0
Gross profit
-95.83%41.69K
22.44K
1.63K
1M
0
0
Operating expense
-49.74%4.72M
-17.88%7.38M
-28.14%6.02M
-18.46%33.75M
-57.00%6.98M
31.62%9.4M
-6.51%8.99M
-0.21%8.38M
5.93%41.39M
70.08%16.23M
Selling and administrative expenses
-24.08%2.07M
-16.04%2.47M
-19.83%2.7M
7.71%12.11M
-2.35%3.08M
1.69%2.72M
4.53%2.95M
30.83%3.36M
33.04%11.24M
29.97%3.15M
-General and administrative expense
-24.08%2.07M
-16.04%2.47M
-19.83%2.7M
7.71%12.11M
-2.35%3.08M
1.69%2.72M
4.53%2.95M
30.83%3.36M
33.04%11.24M
29.97%3.15M
Research and development costs
-60.20%2.66M
-18.78%4.91M
-33.70%3.33M
-28.31%21.54M
-70.72%3.8M
49.58%6.67M
-11.09%6.04M
-13.53%5.02M
-1.88%30.04M
82.35%12.98M
Other operating expenses
----
----
----
0.00%100K
----
----
----
----
--100K
----
Operating profit
44.25%-4.68M
18.13%-7.36M
28.16%-6.02M
1.42%-30.94M
68.14%-5.17M
-17.62%-8.4M
-2,439.02%-8.99M
0.21%-8.38M
19.67%-31.39M
-70.08%-16.23M
Net non-operating interest income expense
Other net income (expense)
-121.73%-21.15K
8,824.69%20.27M
-315.46%-732.88K
77.84%778.49K
-60.36%113.9K
-18.18%97.32K
665.35%227.12K
19,020.18%340.15K
17.55%437.75K
34,353.72%287.34K
Special income (charges)
--0
--20.38M
----
----
----
--0
--0
----
----
----
-Gain on sale of property,plant,equipment
--0
--20.38M
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
-121.73%-21.15K
-148.10%-109.25K
-315.46%-732.88K
77.84%778.49K
-60.36%113.9K
-18.18%97.32K
665.35%227.12K
19,020.18%340.15K
17,271.03%437.75K
34,353.72%287.34K
Income before tax
43.34%-4.7M
247.34%12.91M
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
Income tax
Net income
43.34%-4.7M
247.34%12.91M
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
Net income continuous Operations
43.34%-4.7M
247.34%12.91M
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
Minority interest income
Net income attributable to the parent company
43.34%-4.7M
247.34%12.91M
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
43.34%-4.7M
247.34%12.91M
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
Basic earnings per share
49.54%-0.55
225.41%1.5294
22.22%-0.84
5.41%-4.2
67.11%-0.75
-13.54%-1.09
-2,178.74%-1.2195
10.00%-1.08
41.27%-4.44
-5.56%-2.28
Diluted earnings per share
49.54%-0.55
224.59%1.5194
22.22%-0.84
5.41%-4.2
67.11%-0.75
-13.54%-1.09
-2,195.60%-1.2195
10.00%-1.08
41.27%-4.44
-5.56%-2.28
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -95.83%41.69K22.44K9.3K-71.92%2.81M1.81M1M0010M0
Operating revenue -95.83%41.69K--22.44K--9.3K-71.92%2.81M--1.81M--1M--0--0--10M--0
Cost of revenue 007.67K000
Gross profit -95.83%41.69K22.44K1.63K1M00
Operating expense -49.74%4.72M-17.88%7.38M-28.14%6.02M-18.46%33.75M-57.00%6.98M31.62%9.4M-6.51%8.99M-0.21%8.38M5.93%41.39M70.08%16.23M
Selling and administrative expenses -24.08%2.07M-16.04%2.47M-19.83%2.7M7.71%12.11M-2.35%3.08M1.69%2.72M4.53%2.95M30.83%3.36M33.04%11.24M29.97%3.15M
-General and administrative expense -24.08%2.07M-16.04%2.47M-19.83%2.7M7.71%12.11M-2.35%3.08M1.69%2.72M4.53%2.95M30.83%3.36M33.04%11.24M29.97%3.15M
Research and development costs -60.20%2.66M-18.78%4.91M-33.70%3.33M-28.31%21.54M-70.72%3.8M49.58%6.67M-11.09%6.04M-13.53%5.02M-1.88%30.04M82.35%12.98M
Other operating expenses ------------0.00%100K------------------100K----
Operating profit 44.25%-4.68M18.13%-7.36M28.16%-6.02M1.42%-30.94M68.14%-5.17M-17.62%-8.4M-2,439.02%-8.99M0.21%-8.38M19.67%-31.39M-70.08%-16.23M
Net non-operating interest income expense
Other net income (expense) -121.73%-21.15K8,824.69%20.27M-315.46%-732.88K77.84%778.49K-60.36%113.9K-18.18%97.32K665.35%227.12K19,020.18%340.15K17.55%437.75K34,353.72%287.34K
Special income (charges) --0--20.38M--------------0--0------------
-Gain on sale of property,plant,equipment --0--20.38M--------------0--0------------
Other non- operating income (expenses) -121.73%-21.15K-148.10%-109.25K-315.46%-732.88K77.84%778.49K-60.36%113.9K-18.18%97.32K665.35%227.12K19,020.18%340.15K17,271.03%437.75K34,353.72%287.34K
Income before tax 43.34%-4.7M247.34%12.91M16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M
Income tax
Net income 43.34%-4.7M247.34%12.91M16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M
Net income continuous Operations 43.34%-4.7M247.34%12.91M16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M
Minority interest income
Net income attributable to the parent company 43.34%-4.7M247.34%12.91M16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 43.34%-4.7M247.34%12.91M16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M
Basic earnings per share 49.54%-0.55225.41%1.529422.22%-0.845.41%-4.267.11%-0.75-13.54%-1.09-2,178.74%-1.219510.00%-1.0841.27%-4.44-5.56%-2.28
Diluted earnings per share 49.54%-0.55224.59%1.519422.22%-0.845.41%-4.267.11%-0.75-13.54%-1.09-2,195.60%-1.219510.00%-1.0841.27%-4.44-5.56%-2.28
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
+1.72%
Petroleo Brasileiro SA Petrobras
PBR
+1.11%
Taylor Morrison Home
TMHC
+0.76%
NVIDIA
NVDA
+0.35%
Adobe
ADBE
-0.15%

Unlock the Full List